drugset / Trial / NCT00758589

One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids

NCT00758589

Phase 2 Completed 368 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to evaluate efficacy of AZD1981 in uncontrolled asthmatic patients on maintenance inhaled glucocorticosteroids.

Timeline

Start
2008-09
Primary completion
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1981 Small molecule 50 mg Oral
Subject AZD1981 Small molecule 400 mg Oral
Subject AZD1981 Small molecule 1000 mg Oral

Indications